Telo Genomics Corp.

VANCOUVER, A1 · CIK 0001872138 · Medtech · Public

TeloView® diagnostic platform that measures telomere structure and spatial organization to assess genomic instability

telodx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$98K
3 Form D · Apr 2026
6 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$80,680
Private capital raisedForm D · SEC$10,420
Private capital raisedForm D · SEC$7,346
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2262IMMUNOSHIELD THERAPEUTICS INC.——
2263Mercury Biomed LLC——
2264ORTHOMECHANICA, INC.——
2265Telo Genomics Corp.—$98K
2266BIACURE THERAPIES, INC.——
2267LENA BIOSCIENCES, INC.——
2268Forsagen LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Guido BaechlerDirector
  • Ryan CheungDirector
  • John FarlingerDirector · Executive Officer
  • Sherif LouisExecutive Officer
  • Sabine MaiDirector · Executive Officer · Promoter
  • Ron McGlennenDirector
  • John MeekisonDirector
  • John PriceExecutive Officer
  • Hugh RogersDirector
  • Chris RossExecutive Officer
  • Christopher RossExecutive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.